Roche Pharma India has Introduced Vabysmo (faricimab) in the Indian market. This monoclonal immune response drug targets two critical reasons for vision impairment among the old and diabetic patients. In a proclamation...
Caliway Biopharmaceuticals declared that the US Food and Medication Organization (FDA) permitted Orphan Drug Designation (ODD) to CBL-514 for Dercum's illness treatment. CBL-514 is a lipolysis injection that can diminish nearby subcutaneous fat...
Sandoz, the leader in conventional and biosimilar drugs, has acquired the US biosimilar Cimerli (ranibizumab-eqrn) from Coherus BioSciences, Inc., before expected timetables. The procurement expands on the main Sandoz ophthalmic stage in the US...
Cadila Pharmaceuticals said it has introduced an immunization to prevent flu, a repetitive and far and wide viral infection. The medication firm has presented quadrivalent Cadiflu Tetra immunization, endorsed by the DCGI (Drugs Controller General...
Union Minister of Health and Family Welfare Dr Mansukh Mandaviya launched the Ayush-ICMR Advanced Centre for Integrated Health Research in AIIMS and announced other mega joint initiatives between the Health Ministry and the Ministry of Ayush.
The UK Government's Rare Disease Action Plan 2024 has been published, detailing what the NIHR, DHSC and others have done over the past year to better meet the needs of patients with rare diseases.
In a major move to improve the accuracy and accessibility of breast cancer screening in India, Indira IVF has partnered with BD SurePath.
Johnson and Johnson announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant (amivantamab-vmjw) in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients w
The current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues†- David Sanford Wolfe, Chairman, Aaron Capital, Inc USA.
The Indian active pharmaceutical ingredient (API) industry believes that the Make in India initiative and the PLI (production-linked incentive) scheme will help limit imports from China.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")